Senior Scientist I - Drug Product Formulation & Strategy

AbbVie; North Chicago (IL); Sur place; USD 110 000 - 150 000; Plein temps

Résumé du poste

AbbVie in North Chicago, IL seeks a Senior Scientist I to lead drug product design and formulation strategies for candidate molecules. You will guide cross-functional teams to design, characterize, and optimize drug products for clinical evaluation, ensuring timely delivery of clinical supplies and adherence to quality standards.

The role emphasizes leadership, collaboration, and advancement of biopharmaceutical characterizations of clinical formulations within a dynamic CMC environment.

Qualifications

• Experience in designing and developing drug products for clinical evaluation.
• Lead formulation design for small molecule development candidates.
• Cross-functional collaboration to devise drug delivery and formulation strategies.

Responsabilités

• Lead the formulation design for small molecule development candidates within the AbbVie pipeline.
• Interface with drug product development teams to ensure biopharmaceutical and physicochemical considerations are incorporated into formulation design.
• Advance scientific expertise within function; provide leadership and share expert opinions with teams and management.
• Ensure development of technologies and scientific innovation to formulate small molecules within the pipeline.
• Collaborate with other functions within AbbVie to align strategies supporting drug discovery and development programs.
• Ensure compliance with AbbVie safety, quality and regulatory policies and government regulations.

Description du poste

AbbVie in North Chicago, IL seeks a Senior Scientist I to lead drug product design and formulation strategies for candidate molecules. You will guide cross-functional teams to design, characterize, and optimize drug products for clinical evaluation, ensuring timely delivery of clinical supplies and adherence to quality standards.

The role emphasizes leadership, collaboration, and advancement of biopharmaceutical characterizations of clinical formulations within a dynamic CMC environment.